RJA
TRHC

Raymond James & Associates’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Raymond James & Associates’s Portfolio TRHC Stock Details TRHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,800
Closed -$1K – 3897
2020
Q3 		$1K Sell
13,800
-700
-5% -$34.9K ﹤0.01% 3580
2020
Q2 		$26K Sell
14,500
-900
-6% -$51.5K ﹤0.01% 3427
2020
Q1 		$66K Buy
+15,400
New +$834K ﹤0.01% 3282

Other funds holding TRHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Raymond James & Associates's TRHC Position: Q4 2020 in Review

Raymond James & Associates sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2020, closing a stake of 18,562 shares — an estimated $757K sold.

Raymond James & Associates first reported a position in TRHC in Q2 2017 and held it in 11 quarters. The position peaked at $1.17M in Q4 2019. 163 funds tracked by Wall St. Rank hold TRHC as of Q4 2020.

  • Raymond James & Associates reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Raymond James & Associates sold 18,562 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2020, an estimated $757K.
  • Raymond James & Associates first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q2 2017 and held it in 11 quarters.
  • Raymond James & Associates's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $1.17M in Q4 2019.
  • 163 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2020.

Based on Raymond James & Associates's 13F filing for Q4 2020, filed 12 Feb 2021.